SCHEMBL24309495

SCHEMBL24309495

CSc1cc(-c2ccccc2C)nc(N)n1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSP90AA1 P07900 4/20 0.53
▸ HEXA P06865 1/20 0.48
▸ HEXB P07686 1/20 0.48
▸ ADORA2A P29274 7/20 0.46
▸ ADORA1 P30542 5/20 0.46
▸ NUDT1 P36639 1/20 0.46
▸ DHFR P00374 1/20 0.43
▸ PTPN1 P18031 1/20 0.43
▸ HSP90AB1 P08238 2/20 0.41
▸ C1S P09871 1/20 0.41
▸ MEN1 O00255 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ MAPK10 P53779 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29566853 1.00 HSP90AA1 (0.53) HSP90AA1HEXAHEXBADORA2AADORA1
SCHEMBL24309274 0.83 HSP90AA1 (0.41) HSP90AA1HEXAHEXBADORA2AADORA1
SCHEMBL5749301 0.81 DHFR (0.47) HSP90AA1NUDT1DHFRHSP90AB1MEN1
SCHEMBL29567313 0.80 DHFR (0.45) HSP90AA1ADORA2AADORA1DHFRHSP90AB1
SCHEMBL24309341 0.80 DHFR (0.45) HSP90AA1ADORA2AADORA1DHFRHSP90AB1
Hydrochloric Acid SCHEMBL5748008 0.80 DHFR (0.46) HSP90AA1NUDT1DHFRHSP90AB1MEN1
SCHEMBL30488032 0.80 NUDT1 (0.50) HSP90AA1HEXAHEXBADORA2AADORA1
SCHEMBL29044794 0.80 NUDT1 (0.50) HSP90AA1HEXAHEXBADORA2AADORA1
SCHEMBL24309264 0.78 ADORA2A (0.66) HSP90AA1ADORA2AADORA1HSP90AB1MEN1
SCHEMBL3952089 0.77 HSP90AA1 (0.70) HSP90AA1ADORA2AADORA1NUDT1DHFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230373935-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS, SAN DIEGO 2023-11-23 — — US disclosed
US-20230373935-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS, SAN DIEGO 2023-11-23 — — US disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
WO-2022076626-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230373935-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR CFTR, SCNN1G, SCNN1B HSP90AA1 1490/4885HEXA 1673/4885HEXB 1248/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback